Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Address
500 W. 5TH STREET
AUSTIN, TX 78701
Founded
2016
Number of Employees
75
Website
http://www.shattucklabs.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)